Matthew Gallagher launched Medvi, a GLP-1 telehealth company, from his Los Angeles home in September 2024. Fourteen months ...

Need a solution for your thinning hair line? We took a deep dive into Hims hair growth program to see how it works and who it ...

The telehealth company Hims & Hers has formally initiated its partnership with Novo Nordisk, making FDA-approved GLP-1 medications such as Wegovy and Ozempi ...

Shares of Hims & Hers Health Inc. experienced a notable rally, climbing approximately 6.4% to trade near $20. This upward ...

Longer subscriptions offer lower monthly pricing, with people expected to save up to $1,200 a year on the injection and as ...

Novo Nordisk is offering the subscriptions through telehealth providers Ro, WeightWatchers and LifeMD. Others are expected to ...

The popular GLP-1 weight-loss drug will be available via a subscription program designed to lower costs for self-pay patients ...

Novo Nordisk launched a new discounted subscription program for its Wegovy obesity drugs in the U.S. as it tries to win customers by offering a lower, predictable monthly price.

Novo Nordisk (NVO) stock is in focus as the company launches a Wegovy subscription program via telehealth firms including ...

Few people consult a doctor before attempting weight loss. Hims offers virtual weight loss support for men, including consultations and prescriptions. Hims provides GLP-1 injections, meal replacements ...